lp533401 and Weight-Gain

lp533401 has been researched along with Weight-Gain* in 1 studies

Other Studies

1 other study(ies) available for lp533401 and Weight-Gain

Article	Year
Peripheral Selective Oxadiazolylphenyl Alanine Derivatives as Tryptophan Hydroxylase 1 Inhibitors for Obesity and Fatty Liver Disease. Journal of medicinal chemistry, 2021, 01-28, Volume: 64, Issue:2 Tryptophan hydroxylase 1 (TPH1) has been recently suggested as a promising therapeutic target for treating obesity and fatty liver disease. A new series of 1,2,4-oxadiazolylphenyl alanine derivatives were identified as TPH1 inhibitors. Among them, compound Topics: Adiposity; Alanine; Animals; Anti-Obesity Agents; Diet, High-Fat; Energy Metabolism; Enzyme Inhibitors; Fatty Liver; Glucose Intolerance; Humans; Lipid Metabolism; Liver; Mice; Mice, Inbred C57BL; Microsomes, Liver; Models, Molecular; Tryptophan Hydroxylase; Weight Gain	2021

Article

Year

Peripheral Selective Oxadiazolylphenyl Alanine Derivatives as Tryptophan Hydroxylase 1 Inhibitors for Obesity and Fatty Liver Disease.

Journal of medicinal chemistry, 2021, 01-28, Volume: 64, Issue:2

Tryptophan hydroxylase 1 (TPH1) has been recently suggested as a promising therapeutic target for treating obesity and fatty liver disease. A new series of 1,2,4-oxadiazolylphenyl alanine derivatives were identified as TPH1 inhibitors. Among them, compound

Topics: Adiposity; Alanine; Animals; Anti-Obesity Agents; Diet, High-Fat; Energy Metabolism; Enzyme Inhibitors; Fatty Liver; Glucose Intolerance; Humans; Lipid Metabolism; Liver; Mice; Mice, Inbred C57BL; Microsomes, Liver; Models, Molecular; Tryptophan Hydroxylase; Weight Gain

2021